Project FLUx COntact-CoVID-19 Faculty of Medicine Paris-Saclay
NCT04991246 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 210
Last updated 2023-02-06
Summary
The worldwide health system has been marked by the SARS-CoV-2 pandemic. French educational system has been upset, especially medical schools, which, because of their hospital location, are particularly exposed to the spread of the virus. The medical school of Paris-Saclay University, located within bicetre University Hospital, AP-HP, must therefore adapt on a daily basis to ensure educational continuity. Taking advantage of an exceptional scientific ecosystem, innovative viral epidemic propagation modeling approaches based on both simulation and contact tracing data will be tested in real-life conditions. These propagation models will serve to scientifically optimize future educational organization procedures in this medical school.
Conditions
- Covid19
Interventions
- OTHER
-
Antigenic tests (on saliva samples)
SARS-CoV-2 screening tests: two massive antigenic tests campaigns (on salivary samples).
- OTHER
-
Individual electronic sensor port
Individual electronic sensor recording contacts but not their location (in the form of a bracelet, a key ring or a badge) Contact data collection points (5 maximum, located at compulsory passage points for participants). When a sensor is close to one of these terminals, it discharges its contacts in seconds.
- OTHER
-
Atmospheric measurements of CO2
Atmospheric measurements of CO2 in the relevant closed places of the faculty (lectures / practical work / BU / refectory): battery operated sensors. When a sensor is installed in a place, the ventilation conditions (number of open windows, etc.) as well as the number of people present will be noted.
Sponsors & Collaborators
-
Assistance Publique - Hôpitaux de Paris
lead OTHER
Principal Investigators
-
Olivier LAMBOTTE, Pr · Bicetre Hospital
Study Design
- Allocation
- NA
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-10-14
- Primary Completion
- 2021-12-15
- Completion
- 2022-01-14
Countries
- France
Study Locations
More Related Trials
-
Longitudinal Follow-up of a Population Cohort in a French City With High SARS-CoV-2 Circulation, in Early 2020 [COVID-19]
NCT04644159 ·Status: COMPLETED
-
Biomarkers for Dexamethasone Response in Sars-Cov-2 / COVID-19 Pneumonia
NCT04619693 ·Status: TERMINATED
-
Health Professional Exposure Assessment to Covid-19
NCT04429724 ·Status: COMPLETED ·Phase: NA
-
Study of Clinical and Immune Severity Profiles of Patients Infected With SARS-Cov2 (COVID-19)
NCT04365166 ·Status: UNKNOWN
-
Study of Symptoms Linked to Covid-19 in Residents and Professionals in EHPAD, Associated With a Dual Diagnostic Approach by PCR and Serology: a Cohort in Île-de-France.
NCT04677283 ·Status: COMPLETED
-
Primary Care in AURA for COVID-19
NCT05124145 ·Status: COMPLETED
-
Clinical Characteristics And Outcome Of COVID-19 Infection In Patients With Chronic Respiratory Diseases.
NCT05054127 ·Status: UNKNOWN
-
Host-pathogen Interactions During SARS-CoV-2 Infection
NCT04376476 ·Status: COMPLETED ·Phase: NA
-
Biomarkers for the Prognosis of Influenza in Children
NCT03231995 ·Status: COMPLETED ·Phase: NA
-
Observational Cohort of COVID-19 Patients at Raymond-Poincare
NCT04364698 ·Status: UNKNOWN
-
Human Ab Response & immunoMONItoring of COVID-19 Patients
NCT04373200 ·Status: COMPLETED ·Phase: NA
-
Developement and Evaluation of Serological Assays for COVID-19
NCT04377763 ·Status: UNKNOWN
-
Characterization of Respiratory Microbiota in Susceptibility to Viral Respiratory Infections
NCT03600753 ·Status: UNKNOWN ·Phase: NA
-
Observational, Prospective Clinical Study to Evaluate Biomarkers as Indicators of Acute Bacterial or Viral Infections
NCT01917461 ·Status: COMPLETED
-
Measure of Vaccine Effectiveness to Prevent Hospitalizations for Viral Respiratory Infections in Adults
NCT05582239 ·Status: RECRUITING
-
Evaluation of Quickly Diagnostic Saliva Tests for SARS-CoV-2
NCT04337424 ·Status: COMPLETED
-
HLA-G Immuno-Inhibitor Checkpoint Study in Patients With COVID-19 Infection: Molecular and Cellular Assessment
NCT04613297 ·Status: COMPLETED ·Phase: NA
-
Prospective Evaluation of the Predictive Criteria of Severity for Respiratory Infection Due to COVID-19 Virus
NCT04615676 ·Status: COMPLETED
-
Prevention of Pneumococcal Infections: Impact Collaborative Medico-pharmaceutical Care Structured to Improve Vaccination Coverage of Patients at Risk.
NCT05060146 ·Status: COMPLETED ·Phase: NA
-
Education of Medical Staff to Post Acute Covid susTained sYmptoms
NCT06082258 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
An Observational Study in Patients With Mild to Moderate COVID-19
NCT05366244 ·Status: UNKNOWN
-
InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection FR BL Cohort
NCT04407689 ·Status: TERMINATED ·Phase: PHASE2
-
Virological and Immunological Monitoring in Patients (suspected Of/confirmed With) COVID-19
NCT04904692 ·Status: ACTIVE_NOT_RECRUITING
-
Prognostic Factors of COVID19
NCT04405726 ·Status: UNKNOWN
-
Rapid Detection of COVID-19 by Portable and Connected Biosensor
NCT04367142 ·Status: COMPLETED